
Myeloid Therapeutics
- Home
- Companies
- Myeloid Therapeutics
- Products
- Next-Generation Delivery and Editing ...

Next-Generation Delivery and Editing Technology
Retrotransposons are genetic elements that can replicate through reverse transcription of an RNA transposition intermediate. They contribute to structural changes and, more importantly, to gene regulation. Our proprietary RNA-based, retrotransposon-mediated gene-insertion technology (CREATE) has applications across gene editing and delivery.